TUXEDO-2 trial - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of a legal and workplace rights dispute in India after the National Human Rights Commission notices and the Supreme Court filing intensified focus on the Nashik workplace harassment and coercion case involving Tata Consultancy Services.

TCS Nashik case: NHRC directs three-year POSH audit across all TCS branches

Nexstar Media Group (NASDAQ: NXST) faces post-closing merger shock as judge halts TEGNA integration

Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling

Why Lockheed Martin’s $101.6 m Army award matters more than its size suggests for LMT stock

Sahajanand Medical Technologies completes patient enrolment for TUXEDO-2 trial, assessing the Supraflex Cruz stent in diabetic CAD patients.

Read More

Healthcare Industry News

TUXEDO-2 trial wraps up enrolment: Could Sahajanand Medical Technologies’ stent revolutionise diabetes care?

In a landmark achievement for cardiovascular medicine, Sahajanand Medical Technologies has announced the successful completion of patient enrolment…

byPallavi Madhiraju

August 18, 2024

web analytics